| Stage | CVS | % of rev | GILD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $106B | 100.00% | $8.3B | 100.00% | CVS ×12.78 |
| Gross profit | $47.2B | 44.52% | $6.7B | 81.07% | GILD +36.6pp |
| Operating income | $4.7B | 4.43% | $3.5B | 41.71% | GILD +37.3pp |
| Pre-tax income | $4.0B | 3.75% | $3.1B | 36.90% | GILD +33.2pp |
| Net income | $3.0B | 2.82% | $2.4B | 29.27% | GILD +26.4pp |
| Stage | CVS | GILD | Gap · A − B |
|---|---|---|---|
| Revenue | $106B100.00% | $8.3B100.00% | CVS ×12.78 |
| Gross profit | 44.52%$47.2B | 81.07%$6.7B | GILD +36.6pp |
| Operating income | 4.43%$4.7B | 41.71%$3.5B | GILD +37.3pp |
| Pre-tax income | 3.75%$4.0B | 36.90%$3.1B | GILD +33.2pp |
| Net income |
| 2.82%$3.0B |
| 29.27%$2.4B |
| GILD +26.4pp |
CVS · MCK 10-KMay 9 '25
“Sales to our largest customer, CVS Health Corporation ("CVS"), accounted for approximately 24% of our total consolidated revenues in fiscal 2025 and comprised approximately 23% of total trade accounts receivable at March 31, 2025.”
GILD 10-KFeb 28 '25
“McKesson Corporation 20 % 21 % 20 %”
CVS · CAH 10-KAug 12 '25
“Our largest customer, CVS Health, accounted for 30 percent of our fiscal 2025 revenue.”
GILD 10-KFeb 28 '25
“Cardinal Health, Inc. 26 % 26 % 25 %”